Article Details

New Clinical Trial Will Assess Novel ADC in Drug Resistant HER2+ Breast Cancer

Retrieved on: 2021-10-23 15:13:08

Tags for this article:

Click the tags to see associated articles and topics

New Clinical Trial Will Assess Novel ADC in Drug Resistant HER2+ Breast Cancer. View article details on hiswai:

Excerpt

ARX788 is an ADC that combines a HER2-directed monoclonal antibody with ... total antibody, and pAF-AS269, and incidence of anti-drug antibodies ...

Article found on: www.oncnursingnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up